Human-Induced CD49a


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 07 12 2021
accepted: 19 01 2022
entrez: 21 2 2022
pubmed: 22 2 2022
medline: 2 4 2022
Statut: epublish

Résumé

CD49a

Identifiants

pubmed: 35185911
doi: 10.3389/fimmu.2022.821542
pmc: PMC8854499
doi:

Substances chimiques

Antigens, CD 0
Integrin alpha1 0
Intercellular Signaling Peptides and Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

821542

Informations de copyright

Copyright © 2022 Du, Zhu, Jiao, Nian, Zhang, Zhou, Zheng, Tong, Wei and Fu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Expert Rev Clin Immunol. 2012 Nov;8(8):747-53
pubmed: 23167686
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):E231-40
pubmed: 23271808
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15563-8
pubmed: 16230631
Tissue Antigens. 2004 Jan;63(1):1-12
pubmed: 14651517
Cell Mol Immunol. 2014 Nov;11(6):564-70
pubmed: 25027967
Cell Mol Immunol. 2021 Jul;18(7):1838-1840
pubmed: 34002045
Elife. 2014 Jan 01;3:e01659
pubmed: 24714492
Cell Mol Immunol. 2011 Jan;8(1):1-11
pubmed: 20711229
J Clin Invest. 2013 Apr;123(4):1444-56
pubmed: 23524967
J Immunol. 2013 Apr 15;190(8):3939-48
pubmed: 23487420
Placenta. 2005 Apr;26 Suppl A:S37-41
pubmed: 15837065
Placenta. 2010 Jul;31(7):595-601
pubmed: 20483454
Nat Rev Immunol. 2002 Sep;2(9):656-63
pubmed: 12209134
Reproduction. 2003 Aug;126(2):149-60
pubmed: 12887272
J Clin Invest. 2013 Oct;123(10):4264-72
pubmed: 24091323
Immunity. 2015 Aug 18;43(2):394-407
pubmed: 26287684
J Immunol. 2009 Apr 1;182(7):4085-92
pubmed: 19299706
Blood. 2000 Feb 1;95(3):984-91
pubmed: 10648413
Immunity. 2019 Feb 19;50(2):403-417.e4
pubmed: 30709740
Blood. 2008 Mar 15;111(6):3108-15
pubmed: 18187664
Front Immunol. 2021 May 04;12:640672
pubmed: 34017328
Sci Transl Med. 2020 Apr 1;12(537):
pubmed: 32238574
Gut. 2019 Aug;68(8):1493-1503
pubmed: 30487267
Immunology. 1999 May;97(1):159-65
pubmed: 10447727
Birth Defects Res. 2018 Dec 1;110(20):1531-1538
pubmed: 30467993
Blood. 2003 Sep 1;102(5):1569-77
pubmed: 12730110
Immunity. 2021 Oct 12;54(10):2417-2432.e5
pubmed: 34453879
J Perinat Med. 2006;34(4):272-9
pubmed: 16856814
Biol Reprod. 1999 Feb;60(2):251-61
pubmed: 9915988
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2402-7
pubmed: 21248224
PLoS One. 2016 Oct 13;11(10):e0164353
pubmed: 27736914
Placenta. 2010 Jun;31(6):545-8
pubmed: 20338637
Sci Immunol. 2021 Feb 19;6(56):
pubmed: 33617461
Blood. 2004 Apr 1;103(7):2677-82
pubmed: 14630824
J Leukoc Biol. 2010 Oct;88(4):625-33
pubmed: 20519637
Blood. 2011 Feb 24;117(8):2378-84
pubmed: 21156847
Biol Reprod. 2006 May;74(5):896-904
pubmed: 16452465
Cell Mol Immunol. 2019 May;16(5):430-441
pubmed: 30778167
J Clin Invest. 2004 Sep;114(6):744-54
pubmed: 15372095
Front Immunol. 2018 Oct 16;9:2358
pubmed: 30459756
J Exp Med. 2003 Oct 20;198(8):1201-12
pubmed: 14568979
Immunity. 2005 Mar;22(3):295-304
pubmed: 15780987
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3378-83
pubmed: 17360654
Reprod Biol Endocrinol. 2009 Jan 26;7:8
pubmed: 19171054
Nat Med. 2006 Sep;12(9):1065-74
pubmed: 16892062
J Exp Med. 2000 Jul 17;192(2):259-70
pubmed: 10899912
J Immunol. 2020 Jun 15;204(12):3171-3181
pubmed: 32332109
Front Immunol. 2018 Sep 25;9:2126
pubmed: 30319610
Nat Commun. 2017 Aug 9;8(1):224
pubmed: 28794456
Immunology. 2014 Apr;141(4):483-9
pubmed: 24303897
Immunity. 2017 Dec 19;47(6):1100-1113.e6
pubmed: 29262349
Annu Rev Immunol. 2006;24:257-86
pubmed: 16551250
Immunol Cell Biol. 2011 Feb;89(2):216-24
pubmed: 20567250

Auteurs

Xianghui Du (X)

The Department of Obstetrics and Gynecology, First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Huaiping Zhu (H)

The Section of Experimental Hematology, First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Defeng Jiao (D)

The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Zhigang Nian (Z)

The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Jinghe Zhang (J)

The Department of Obstetrics and Gynecology, First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Yonggang Zhou (Y)

The Department of Obstetrics and Gynecology, First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Xiaohu Zheng (X)

The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Xianhong Tong (X)

The Department of Obstetrics and Gynecology, First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Haiming Wei (H)

The Department of Obstetrics and Gynecology, First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Binqing Fu (B)

The Department of Obstetrics and Gynecology, First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Institute of Immunology, University of Science and Technology of China, Hefei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH